Futu News report dated June 23, this Thursday $CLOUDR (09955.HK)$An announcement was made stating the offering will take place from June 23 to June 28. The company plans to issue 19 million shares, including 1.9 million shares for public offering, and 17.1 million shares for international offering. The issue price is set at HKD 30.50 per share, with a minimum lot size of 100 shares. It is expected to be listed on July 6.
The prospectus shows that,Zhiyun Health provides medical supplies and SaaS products to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultations and prescription issuance to patients, all centered around chronic disease management.Zhiyun Health expects to continue generating most of its revenue in the near future by selling medical supplies to hospitals and pharmacies.
By providing solutions to all major participants in the healthcare value chain, including hospitals, pharmacies, pharmaceutical companies, patients, and doctors, Zhiyun Health aims to lead China’s digital chronic disease management market. According to a Frost & Sullivan report, based on the deployment volume of SaaS for Chinese hospitals and pharmacies as of December 31, 2021, and the number of online prescriptions issued through Zhiyun Health's services in 2021,Zhiyun Health is the largest provider of digital chronic disease management solutions in China.。
Zhiyun Health offers in-hospital solutions, pharmacy solutions, and personal chronic disease management solutions.In-hospital solutionsIncluding the sale of medical devices, consumables, and pharmaceuticals, hospital SaaS, and digital marketing services for pharmaceutical companies, mainly selling medical devices...